Sarah James
Stock Analyst at Cantor Fitzgerald
(1.95)
# 3,137
Out of 5,030 analysts
293
Total ratings
34.53%
Success rate
-7.65%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UHS Universal Health Services | Reiterates: Neutral | $227 | $204.56 | +10.97% | 26 | Oct 7, 2025 | |
| THC Tenet Healthcare | Reiterates: Overweight | $190 | $200.00 | -5.00% | 22 | Oct 7, 2025 | |
| SGRY Surgery Partners | Reiterates: Overweight | $36 | $20.57 | +75.01% | 13 | Oct 7, 2025 | |
| HCAT Health Catalyst | Reiterates: Neutral | $4 | $3.05 | +31.36% | 8 | Oct 7, 2025 | |
| HCA HCA Healthcare | Reiterates: Overweight | $444 | $426.16 | +4.19% | 21 | Oct 7, 2025 | |
| ACHC Acadia Healthcare Company | Reiterates: Neutral | $25 | $24.17 | +3.46% | 16 | Oct 7, 2025 | |
| UNH UnitedHealth Group | Reiterates: Overweight | $440 | $356.60 | +23.39% | 18 | Aug 26, 2025 | |
| MOH Molina Healthcare | Reiterates: Neutral | $210 | $192.68 | +8.99% | 13 | Aug 26, 2025 | |
| CVS CVS Health | Reiterates: Overweight | $78 | $82.52 | -5.48% | 15 | Aug 26, 2025 | |
| CNC Centene | Reiterates: Neutral | $38 | $35.27 | +7.74% | 15 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $365 | $299.27 | +21.96% | 22 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 → $28 | $19.34 | +44.78% | 15 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $290 | $275.01 | +5.45% | 21 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $485 | $348.77 | +39.06% | 20 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $29 | $19.45 | +49.10% | 6 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $15 | $6.08 | +146.71% | 11 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $5 | $1.16 | +331.03% | 8 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $10 | $8.53 | +17.23% | 2 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $133 | $125.88 | +5.66% | 6 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $42 | $20.89 | +101.05% | 3 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $5 | $5.34 | -6.28% | 2 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $9.86 | -49.29% | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $17.12 | +22.66% | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $76.93 | -49.30% | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $193 | $62.98 | +206.45% | 2 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $3.08 | - | 2 | Mar 1, 2017 |
Universal Health Services
Oct 7, 2025
Reiterates: Neutral
Price Target: $227
Current: $204.56
Upside: +10.97%
Tenet Healthcare
Oct 7, 2025
Reiterates: Overweight
Price Target: $190
Current: $200.00
Upside: -5.00%
Surgery Partners
Oct 7, 2025
Reiterates: Overweight
Price Target: $36
Current: $20.57
Upside: +75.01%
Health Catalyst
Oct 7, 2025
Reiterates: Neutral
Price Target: $4
Current: $3.05
Upside: +31.36%
HCA Healthcare
Oct 7, 2025
Reiterates: Overweight
Price Target: $444
Current: $426.16
Upside: +4.19%
Acadia Healthcare Company
Oct 7, 2025
Reiterates: Neutral
Price Target: $25
Current: $24.17
Upside: +3.46%
UnitedHealth Group
Aug 26, 2025
Reiterates: Overweight
Price Target: $440
Current: $356.60
Upside: +23.39%
Molina Healthcare
Aug 26, 2025
Reiterates: Neutral
Price Target: $210
Current: $192.68
Upside: +8.99%
CVS Health
Aug 26, 2025
Reiterates: Overweight
Price Target: $78
Current: $82.52
Upside: -5.48%
Centene
Aug 26, 2025
Reiterates: Neutral
Price Target: $38
Current: $35.27
Upside: +7.74%
Aug 26, 2025
Reiterates: Overweight
Price Target: $365
Current: $299.27
Upside: +21.96%
Aug 8, 2025
Maintains: Overweight
Price Target: $26 → $28
Current: $19.34
Upside: +44.78%
May 1, 2025
Reiterates: Neutral
Price Target: $290
Current: $275.01
Upside: +5.45%
Apr 23, 2025
Reiterates: Overweight
Price Target: $485
Current: $348.77
Upside: +39.06%
Mar 11, 2025
Maintains: Overweight
Price Target: $20 → $29
Current: $19.45
Upside: +49.10%
Mar 11, 2025
Reiterates: Overweight
Price Target: $15
Current: $6.08
Upside: +146.71%
Sep 20, 2024
Reiterates: Overweight
Price Target: $5
Current: $1.16
Upside: +331.03%
Aug 20, 2024
Reiterates: Overweight
Price Target: $10
Current: $8.53
Upside: +17.23%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $133
Current: $125.88
Upside: +5.66%
Aug 22, 2023
Reiterates: Overweight
Price Target: $42
Current: $20.89
Upside: +101.05%
Sep 15, 2022
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $5.34
Upside: -6.28%
Aug 19, 2022
Maintains: Overweight
Price Target: $7 → $5
Current: $9.86
Upside: -49.29%
Aug 8, 2022
Maintains: Overweight
Price Target: $14 → $21
Current: $17.12
Upside: +22.66%
Aug 12, 2021
Initiates: Overweight
Price Target: $39
Current: $76.93
Upside: -49.30%
Sep 15, 2017
Upgrades: Overweight
Price Target: $193
Current: $62.98
Upside: +206.45%
Mar 1, 2017
Downgrades: Underweight
Price Target: n/a
Current: $3.08
Upside: -